The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,110.00
Bid: 1,118.00
Ask: 1,124.00
Change: 1.00 (0.09%)
Spread: 6.00 (0.537%)
Open: 1,105.00
High: 1,133.00
Low: 1,099.00
Prev. Close: 1,109.00
BUR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman & Co Research: Burford Capital (BUR): Next $1.6bn of investments to boost returns

3 Jan 2019 10:30

Hardman & Co Research Hardman & Co Research: Burford Capital (BUR): Next $1.6bn of investments to boost returns 03-Jan-2019 / 10:30 GMT/BST


Hardman & Co Research: Next $1.6bn of investments to boost returns

Burford has announced access to almost $1bn of new capital, which, combined with its balance sheet, gives a new and financially attractive structure for how the next $1.6bn of litigation finance investments will be made. The most significant part of this is a new strategic capital relationship with a sovereign wealth fund (SWF). The SWF and Burford have committed a $1bn pool of capital, with the former supplying $667m. Burford will supply the remaining one-third of the capital, but receive 60% of the investment profits. In addition, 50% of the new investments made will be allocated to the pool over the next four years, or until the pool is invested.

Please click here for the full report:

https://www.hardmanandco.com/research/corporate-research/next-1-6bn-of-investments-to-boost-returns/

To contact us: Hardman & Co 35 New Broad Street London EC2M 1NH www.hardmanandco.comFollow us on Twitter @HardmanandCo Contact: Dr Brian Moretta +44 20 7194 7622 bm@hardmanandco.com

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 21 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

763163 03-Jan-2019 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
9th Sep 202112:12 pmRNSInterim Results for six months ended 30 June 2021
26th Aug 20213:00 pmRNSNotice of 1H21 Results Call Registration Details
23rd Aug 20217:00 amRNSBusiness Performance Update and US GAAP Conversion
16th Jul 20217:00 amRNSResolution of Akhmedov enforcement matter
23rd Jun 20217:30 amRNSResults of Tender Offer for Burford's 2022 Bonds
22nd Jun 20212:30 pmRNSDirector/PDMR Shareholding
10th Jun 202112:00 pmRNSNotice of 1H21 Results & Earnings Call
8th Jun 202112:00 pmRNSSterling FX Rate for 2020 Final Dividend
7th Jun 20213:00 pmRNSTR1 - Notification of Major Holdings
4th Jun 202112:00 pmRNSRetail Shareholder Call Registration Details
27th May 202111:15 amRNSTender Offer for Burford Capital PLC's 2022 Bonds
21st May 20216:09 pmRNSResult of AGM
21st May 20213:00 pmRNSNotice of Retail Shareholder Call on June 18, 2021
7th May 202110:30 amRNSDirector/PDMR Shareholding
30th Apr 20217:00 amRNSKenneth Brause Appointed Chief Financial Officer
16th Apr 202112:00 pmRNSNotice of 2021 AGM
12th Apr 202110:20 amRNSDirector/PDMR Shareholding
7th Apr 20215:16 pmRNSCompleted Share Purchase by Employee Benefit Trust
6th Apr 20214:31 pmRNSDirector/PDMR Shareholding
6th Apr 20217:00 amRNSClosing of Private Offering of Senior Notes
31st Mar 202110:00 amRNSDirector/PDMR Shareholding
29th Mar 20217:00 amRNSPricing and Upsizing of Senior Notes Offering
26th Mar 20217:00 amRNSIntended Share Purchase by Employee Benefit Trust
24th Mar 20213:00 pmRNSBurford Capital enhances its team of experts
24th Mar 202112:00 pmRNSAvailability of Annual Report
24th Mar 202112:00 pmRNSPrivate Offering of Senior Notes
24th Mar 202112:00 pmRNSFull Year Results 2020
10th Mar 20212:00 pmRNSNotice of FY20 Earnings Call Registration Details
17th Feb 202112:00 pmRNS2020 Business Update & Dividend Reinstatement
4th Feb 20212:00 pmRNSMove to Electronic Shareholder Communications
14th Jan 202112:00 pmRNSNotice of FY20 Update & Preliminary Results
4th Jan 20214:45 pmRNSTR1 - Notification of Major Holdings
4th Jan 20214:45 pmRNSTR1 - Notification of Major Holdings
21st Dec 20207:00 amRNSAndrea Muller Appointed Non-Executive Director
5th Nov 20202:59 pmRNSNotification of transactions by PDMRs
19th Oct 20202:30 pmRNSBurford Capital Share Trading Begins on NYSE
16th Oct 20202:19 pmRNSNotification of transactions by PDMRs
8th Oct 20202:28 pmRNSNotification of transactions by PDMRs
8th Oct 202011:00 amRNSTR1 - Notification of Major Holdings
1st Oct 20207:00 amRNSUS SEC Declares Registration Statement Effective
1st Oct 20207:00 amRNSInterim Results for six months ended 30 June 2020
29th Sep 20209:00 amRNSDespatch of Shareholder Letter on Dual Listing
29th Sep 20207:00 amRNSUpdate on Proposed NYSE Listing
28th Sep 20202:00 pmRNSChange of Registered Office
17th Sep 20202:00 pmRNSNotice of 1H20 Earnings Call Registration Details
14th Sep 20207:00 amRNSNotice of 1H20 Results & Earnings Call
14th Sep 20207:00 amRNSUpdate on Plan to Dual List in the US and UK
18th Aug 202012:59 pmRNSTR1 - Notification of Major Holdings
7th Aug 20204:00 pmRNSBurford Capital appoints Numis as its NOMAD
7th Jul 20207:00 amRNSFiling With SEC For US Stock Exchange Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.